Pressure Biosciences Inc - ESG Rating & Company Profile powered by AI
This Disclosure rating covers 17 UN SDGs including: 'No Poverty', 'Climate Action' and 'Life below Water'. The webpage displays a free Sustainability assessment for Pressure Biosciences Inc. Detailed Sustainability analysis of Pressure Biosciences Inc can be accessed by signing in.
Pressure Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 8.0, social score of 2.7 and governance score of 8.0.
6.2
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
427 | Scancell Holdings PLC | 6.3 | High |
427 | Verastem Inc | 6.3 | High |
450 | Pressure Biosciences Inc | 6.2 | High |
450 | Cannasouth Ltd | 6.2 | High |
450 | CareDx International AB | 6.2 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Pressure Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Does Pressure Biosciences Inc disclose current and historical energy intensity?
Does Pressure Biosciences Inc report the average age of the workforce?
Does Pressure Biosciences Inc reference operational or capital allocation in relation to climate change?
Does Pressure Biosciences Inc disclose its ethnicity pay gap?
Does Pressure Biosciences Inc disclose cybersecurity risks?
Does Pressure Biosciences Inc offer flexible work?
Does Pressure Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Pressure Biosciences Inc disclose the number of employees in R&D functions?
Does Pressure Biosciences Inc conduct supply chain audits?
Does Pressure Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Pressure Biosciences Inc conduct 360 degree staff reviews?
Does Pressure Biosciences Inc disclose the individual responsible for D&I?
Does Pressure Biosciences Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Pressure Biosciences Inc disclose current and / or historical scope 2 emissions?
Does Pressure Biosciences Inc disclose water use targets?
Does Pressure Biosciences Inc have careers partnerships with academic institutions?
Did Pressure Biosciences Inc have a product recall in the last two years?
Does Pressure Biosciences Inc disclose incidents of discrimination?
Does Pressure Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Has Pressure Biosciences Inc issued a profit warning in the past 24 months?
Does Pressure Biosciences Inc disclose parental leave metrics?
Does Pressure Biosciences Inc disclose climate scenario or pathway analysis?
Does Pressure Biosciences Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Pressure Biosciences Inc disclose the pay ratio of women to men?
Does Pressure Biosciences Inc support suppliers with sustainability related research and development?
Does Pressure Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Pressure Biosciences Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Pressure Biosciences Inc involved in embryonic stem cell research?
Does Pressure Biosciences Inc disclose GHG and Air Emissions intensity?
Does Pressure Biosciences Inc disclose its waste policy?
Does Pressure Biosciences Inc report according to TCFD requirements?
Does Pressure Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Pressure Biosciences Inc disclose energy use targets?
Does Pressure Biosciences Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Pressure Biosciences Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Pressure Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp.